The clinical performance is complex and often involves multi-systematic stress. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD accompanying diagnoses require individual development, typically including pharmacotherapy, rehabilitation interventions, regular follow-up, and multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many infectious respiratory digestive and endocrine disorders that were previously difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the diagnosis of PF-ILD accompanying pathologies. The platform serves the China International Medical Service System, a team of domestic and international experts with authority in the field of infectious respiratory digestive and endocrine disorders, to provide the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.